LogicBio Therapeutics

About:

LogicBio develops gene therapy vectors for previously incurable genetic and infectious diseases.

Website: http://www.logicbio.com

Twitter/X: logicbio

Top Investors: Andera Partners, OrbiMed, Arix Bioscience, SBI Japan-Israel Innovation Fund, Oxford Finance LLC

Description:

LogicBio develops gene therapy vectors for previously incurable genetic and infectious diseases. It is committed to delivering genetic medicine to pediatric patients with rare diseases. Their proprietary technology based on the non-pathogenic adeno-associated viral vector offers superior efficiency and safety compared to all competitors on the market and is uniquely suited for the treatment of children as well as adults.

Total Funding Amount:

$69M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Foster City, California, United States

Founded Date:

2014-01-01

Contact Email:

contact(AT)logicbio.com

Founders:

Adi Barzel, Frederic Chereau, Leszek Lisowski, Mark Kay

Number of Employees:

51-100

Last Funding Date:

2021-01-01

IPO Status:

Delisted

Industries:

© 2025 bioDAO.ai